Abstract 5165: Novel RAS inhibitors DC070-547 and ADT-006 potently and selectively inhibit the growth of pancreatic tumor cells harboring constitutively activated RAS by blocking RAS-effector binding and signaling
Tyler Mattox(USA Mitchell Cancer Institute), Gary A. Piazza(Auburn University), Adam B. Keeton(Washburn University), Ashley S. Lindsey(USA Mitchell Cancer Institute), Kevin J. Lee(University of Alabama at Birmingham), Xi Chen(Jilin Province Science and Technology Department), Bing Zhu(China University of Geosciences (Beijing)), Michael J. Boyd, Jacob Valiyaveettil(USA Mitchell Cancer Institute), Luciana Madeira da Silva(USA Mitchell Cancer Institute)
Cited by 0
Related Papers
Ligand steric properties
|Coordination Chemistry Reviews|1993|210
Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects
|Journal of Experimental & Clinical Cancer Research|2018|176
A Sialyltransferase Mutant with Decreased Donor Hydrolysis and Reduced Sialidase Activities for Directly Sialylating Lewis<sup>x</sup>
|ACS Chemical Biology|2012|169
Cardiac Troponin I Gene Knockout
|Circulation Research|1999|157
CD147 receptor is essential for TFF3-mediated signaling regulating colorectal cancer progression
|Signal Transduction and Targeted Therapy|2021|81